In our previous study, we demonstrated that FAM111B is significantly overexpressed in ovarian cancer (OV) compared to adjacent non-cancerous tissues, and that its expression is linked to an aggressive pathology and poor prognosis [10]. Here, FAM111B is linked to ovarian cancer.